A new study in the International cardiovascular journal Circulation shows that cigarette smokers who switch entirely to e-cigarettes reduce their risk of heart disease by 34 percent. Another study, published on the international healthcare website Cochrane by Oxford and Auckland universities and Queen Mary University of London in collaboration with the National Institute for Health Research and Cancer Research UK, also concluded that e-cigarettes were safer and more effective than smoking cessation methods such as nicosubstitution therapy.
According to a new study published in the International Journal of Cardiology Circulation, after analyzing data from 32,000 adult tobacco users and combining data on e-cigarette and traditional cigarette users with heart disease rates, There was a clear link between traditional cigarette use and heart disease, with a 1.8-fold higher risk compared with non-smokers, while there was no clear link between e-cigarette use and heart disease.
Another study in the article collected data from 175,546 U.S. respondents who participated in the annual National Health Interview Survey between 2014 and 2019. The analysis also found that full e-cigarette use did not increase the risk of heart disease. Diane Caruan, an internal correspondent for International vaping News, revealed a study titled “Tobacco Use Disorders and Cardiovascular Health,” which found that quitting smoking or completely using e-cigarettes could reverse the incidence of acute and chronic cardiovascular disease relatively quickly. Smokers who switched completely to e-cigarettes reduced their risk of heart disease by 34 percent.
In a joint study by the Universities of Oxford, Auckland and Queen Mary University of London, as well as the National Institutes of Health and Cancer Research UK, The research paper “Electronic cigarettes for smoking cessation”, published in Cochrane, an international website for healthcare academics, systematically investigated the question of the effectiveness, tolerance and safety of e-cigarettes in helping smokers achieve long-term cessation.
The paper included 78 completed studies with 22,052 subjects and conducted 40 randomized trials and 38 non-randomized trials. From the study, there is significant evidence that those randomized to nicotine e-cigarette therapy have significantly higher quit rates than those randomized to nicotine replacement therapy (RR 1.63, 95%CI 1.30 to 2.04; I squared = 10%; 6 studies, 2378 subjects); Data from non-randomized studies are consistent with data from randomized studies showing higher quit rates with e-cigarettes.
The researchers said there was no evidence of serious harm from nicotine e-cigarettes during the trial, which had a higher quitting rate than nicotine replacement therapy and were effective in helping smokers quit for at least six months.
References Diane Caruana. Study: Switching from Smoking to Vaping Reduces Heart Disease Risk by 34%. Circulation, 2022
Hartmann-Boyce J; Lindson N; Butler AR, et al. Electronic cigarettes for smoking cessation. Cochrane Library, 2022
Post time: Dec-09-2022
